Getting to know the chief pharmaceutical officer's clinical fellows Justin, Tahmina and Khola

| March 22, 2018

article image
I am currently based at Bupa and work alongside two fellows from the National Medical Director’s Clinical Fellow Scheme. Prior to the scheme I gained experience in various pharmacy specialities within secondary care. I am primarily a surgical specialist pharmacist although I have undertaken roles in clinical governance, critical care and most recently as an independent prescriber in pain. I also have a keen interest in education and currently also work for Robert Gordon University as part of their pharmacy postgraduate courses. My days are focused on one of several agreed work streams including clinical governance, the EU Falsified Medicines Directive and digital health applications. Within these work streams my level of responsibility varies from providing support as a technical expert to both leading and managing the project. There are also many opportunities which have arisen to undertake specialist training such as strategy or project management.

Spotlight

Pharmaceutical Compliance Monitor

Pharma Compliance Monitor (PCM) is only publication that spotlights regulatory and compliance news and developments for the pharmaceutical and biotechnology communities. PCM’s ongoing goal is to create a place where pharmaceutical and biotechnology professionals and executives can go to stay informed, interact and learn. Read by senior compliance professionals and executives at many of the largest research-based pharmaceutical and biotechonology manufacturers, PCM speaks to the decision maker faced with making mission critical choices that anchor best-in-class corporate compliance and ethics programs.

OTHER ARTICLES

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | March 2, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Spotlight

Pharmaceutical Compliance Monitor

Pharma Compliance Monitor (PCM) is only publication that spotlights regulatory and compliance news and developments for the pharmaceutical and biotechnology communities. PCM’s ongoing goal is to create a place where pharmaceutical and biotechnology professionals and executives can go to stay informed, interact and learn. Read by senior compliance professionals and executives at many of the largest research-based pharmaceutical and biotechonology manufacturers, PCM speaks to the decision maker faced with making mission critical choices that anchor best-in-class corporate compliance and ethics programs.

Events